PofoliaShared via Pofolia

Frontiers in Medical Technology· 2026Q1· Review

Biomechanical stabilization of the keratoconic cornea: a review of current therapeutic strategies

Graziana Maria Ragonese, Edoardo Grosso, Dario Carbonaro, Elena Torta et al.

Short summary

Keratoconus management is shifting from visual correction to biomechanical stabilization, with corneal collagen crosslinking (CXL) as the current standard for progressive cases, increasing stromal stiffness by forming new covalent bonds.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Keratoconus is characterized by stromal thinning and biomechanical weakening, leading to visual impairment.
  • Corneal collagen crosslinking (CXL) is the current standard treatment, increasing stromal stiffness by forming additional covalent bonds.
  • Intracorneal ring segments provide geometric improvement but have limited predictability.
  • Emerging therapies aim for multimodal strategies including cell-based therapies and tissue-engineered scaffolds.
  • Future management will require biomechanical assessment and predictive modeling for individualized treatment.

AI-generated from the title and abstract; the full text is not read.

Abstract

Keratoconus is a progressive corneal ectatic disorder characterized by stromal thinning and biomechanical weakening of the cornea, leading to progressive corneal protrusion and visual impairment. Therapeutic strategies have evolved from visual correction toward approaches specifically targeting the biomechanical instability underlying disease progression. This review provides a biomechanical perspective on current and emerging strategies for the biomechanical stabilization of the keratoconic cornea. Conservative treatments based on contact lenses remain essential for visual rehabilitation but do not modify the underlying ectatic process. Corneal collagen crosslinking represents the reference treatment for progressive keratoconus, as it increases stromal stiffness through the formation of additional covalent bonds. However, its efficacy depends on treatment protocol, epithelial status, corneal thickness, and disease stage. Corneal implants, i.e., synthetic intracorneal ring segments and corneal allogenic intrastromal ring segments, provide stretch-induced geometric improvement of the corneal shape and, consequently, of visual acuity, although predictability remains limited. Combined approaches, such as ring implantation followed by cross-linking, aim to integrate corneal reshaping with intrinsic stromal reinforcement. Emerging approaches, including cell-based therapies, and implantation of stromal lenticule or tissue-engineered scaffolds, suggest a future shift toward a multimodal therapeutic strategy integrating biomechanical stabilization, restoration of stromal structure, and biological regeneration. Advancing keratoconus management will require objective biomechanical assessment and predictive modeling tools to guide individualized treatment planning and improve outcome predictability. Ultimately, future management should increasingly incorporate a biomechanical perspective, with interventions designed to modify the mechanical behavior of the ectatic cornea, arrest progression, and restore functional corneal integrity.

The authors' abstract, as published at the source. Frontiers in Medical Technology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Radiology, Nuclear Medicine and Imaging

Radiology, Nuclear Medicine and ImagingMedicine